🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thanks to Miriam Agyakomah Osei, MD Charlotte Story Kelly Schuering Maureen Achebe @BrighamHeme @Brigham_DI Brigham and Women's Hospital and many others for helping us develop and sustain the heme team as a tangible way to address healthcare inequities!

A true labor of love developing the heme team with the support of Miriam Agyakomah Osei, MD Kelly Schuering Charlotte Story Maureen Achebe @BrighamHeme @Brigham_DI Brigham and Women's Medicine Residents ❤️

WOW this project is everything I hoped and worked for since medical school. I am so excited!! Huge thanks to Doris Duke Foundation ASH and all 24 health systems for trusting me as your leader!

I never thought I’d be so proud to be part of something so DANC Look forward to this paradigm shifting work to provide evidence that will further eliminate race-based medicine

Fascinating story in ASH Clinical News on the importance of accurate reference ranges! Thanks to Doris Duke Foundation and ASH we are already making strides in this space. 🩸💪🧬 ashpublications.org/ashclinicalnew…

Check out our piece on anticoagulation and antiplatelet agent use among patients with VWD and cardiac disease featured in Blood Advances! Huge thanks to @NTConnell and @BrighamHeme for the help answering this critical question! ashpublications.org/bloodadvances/…

Such a pleasure writing this NEJM interactive case with an all-star team where we discuss a patient with sickle cell disease I saw on the @BrighamHeme Brigham and Women's Hospital heme team. Check it out! 👉 nejm.org/doi/abs/10.105…

Make Duffy antigen testing easy to order. Make interpretation simple. Identify Duffy-null Associated Neutrophil Counts (#DANC) to facilitate appropriate medication dosing, avoid unnecessary work up and minimize systemic bias. Lauren Merz Boston Medical Center Jean francis

So excited to talk about the Duffy null phenotype and how to talk about race and racism in medicine. Come join us! ASH Doris Duke Foundation #HJ24 #MedEd

ASH CRTI where experts ➡️ mentors, twitter connections ➡️ human, Phase III RCTs ➡️ cohort studies, & likeminded colleagues ➡️ lifelong friends Heme friends hoping to improve care through research (peds, adult, classical, malignant), consider it! #ASHCRTI ASH

Cheers to STAT and Usha Lee McFarling for writing a brilliant piece on a nuanced subject that impacts millions of people. Read about our Duffy work and impact on patients here 👉statnews.com/2024/09/09/emb… @BrighamHeme Dana-Farber News Mass General Cancer Center Mass General Brigham @Brigham_DI

Researchers like hematologist Lauren Merz say that using race in medicine can be problematic. Vanessa Apea's story is one example why.

Ever wondered what STRUCTURAL RACISM is? Important work from my friend Stephen Hibbs in JAMA Network Open Those with Duffy null associated low neutrophil counts are excluded from cancer trials + optimal therapy A🧵 @krutbvora, @cslathan, J Mark Sloan, Lauren Merz, Dr Vanessa Apea

Race is not a biological truth, but genetic variation is, and failure to acknowledge that can cause patient harm. Hematologist Lauren Merz explains the impact of ancestry in the case of the Duffy-null phenotype, a characteristic frequently present in people of West African and

🤰VTE is a leading cause of morbidity and mortality in pregnancy. This new JTH in Clinic Review covers evidences on VTE diagnosis and management, thrombophilia testing, and thromboprophylaxis in pregnancy. A must-read for clinicians! ✍️ Lauren Merz Fionnuala Ní Áinle Read it here:

Huge thank you to Multiple Myeloma RF for being a leader in integrating Duffy status into clinical trial design. Wonderful opportunity to be a part of this trailblazing group!

Such fun writing a review of thrombotic complications in pregnancy for JTH with some of my hematology idols!🩸👑🧪 Fionnuala Ní Áinle Check it out! 👉 secure-web.cisco.com/1fyVbwAGKjLFIq…

Many absolute neutrophil count thresholds in cancer care do not account for normal levels in people with the Duffy null phenotype— the majority of whom are Black or Middle Eastern. 👇Check out some strategies to address systemic racism in cancer care! nejm.org/doi/full/10.10…

.Lauren Merz presents a case for universal Duffy testing in infants to mitigate the long-term patient impact of Duffy null phenotype, ⬇️ ANC & healthcare costs #ASH24, mentored by George Goshua, MD MSc YaleHematology Yale School of Medicine ASH American Academy of Pediatrics

Join Lauren Merz tonight at 5 PM PST on ASH’s virtual platform during the #ASH24 poster walk highlighting her work, Assessing the Contribution of Duffy Null Phenotype to Disparities in Eligibility Criteria for Clinical Trials for Newly-Diagnosed Colorectal Cancer.